Nagpur: The Maharashtra Food and Drugs Administration (FDA) has initiated investigations into alleged presence of worms in some capsules in Nagpur, manufactured by a Goan pharmaceutical company and withdrawn the entire stock from the state.

Live worms were detected in Elferri capsules by a patient, who had purchased the medicine from a chemist' shop at Ramdeshpeth on October 14.

The FDA commissioner Uttam Khobragade said all the stock of a particular batch of the capsule has been withdrawn from the entire state.

Once the laboratory reports are received, FDA will prosecute the Goa-based company, he added.

Meanwhile, FDA assistant commissioner A P Choudhury said in Nagpur that the administration has prohibited a stock of 2,833 capsules in the city, though they have not found any worm in the stock.

The samples of batch number ERL 2006 with manufacturing date of May 2002 and expiry in April 2004, have been collected and sent for testing, FDA sources added.

PTI